Mikhail Blagosklonny, an oncologist at Roswell Park Cancer Institute, has found what many refer to as a magic formula for anti-aging. This formula is known as the rapamycin analog, an analog that could powerfully impact both cancer and anti-aging. This particular analog, known as Everolimus, is the one to watch for the miracle of anti-aging. Additionally, the anti-aging is an extra benefit with a stronger immune system being the main focus for those who are considered to be elderly. These facts are essential to the understanding of research and how the future looks for the elderly as they face immortality. This research is so forthcoming, that it causes other doctors to consider how geriatric care will fare when aging has been slowed down so dramatically.
Know more: http://gettingstronger.org/tag/mikhail-blagosklonny/
There are numerous ways in which Blagosklonny has contributed to the field of medicine, and furthermore, the research he has conducted regarding the rapaymycin analog now makes him the foremost expert in this particular area of oncology. Additionally, this research has also been submitted into his peer reviewed journal, Oncotarget, sharing this research and information with other physicians that work in oncology as well as closely related specialties. As the department head of Cell Stress Biology at Roswell Institute for Cancer, this research will ultimately extend to see how this analog or similar analogs in other life forms can slow down aging and improve the overall health of any animal or mammal.
As the research continues, there is a search for whether or not rapamycin directly impacts cancer. There have already been cases in which this has been proven to be true both in young and old animals. Their traits and phenotypes have all been considered when considering their lifetime expectancy as well as their ability to ward off disease and much more. This has now led to the FDA approval of Rapamycin, and it is already being actively used in veterinary offices around the world. Studies have included both short-term and long-term effects of the use of this drug. Visit ResearchGate to know more about Mikhail’s latest work.
Mikhail Blagosklonny has been deemed as one of the foremost researchers and experts in the field oncology, and he has been regarded as the source for information as it pertains to current and future research on rapamycin and other ways in which it can be used.
The results from a new clinical trial have proven extremely beneficial in the world of medicine. It has provided news that a high-dosage of immunosuppressive therapy that is followed by a transplant of a person’s very own stem cells can create a remission of MS- multiple sclerosis. Multiple Sclerosis is an autoimmune disease that targets the central nervous system. The results showed that five years after treatment, about sixty-nine percent of the clinical trial participants, survived. These participants survived without experiencing any relapse of multiple sclerosis symptoms or disability progression. The clinical trial volunteers didn’t take medications for multiple sclerosis.
The clinical trial was sponsored by the NIAID, which is the National Institute of Allergy and Infectious Diseases. In 2014, the researchers of this clinic trial published their results. Currently, their results for five years is online in a medical journal, called Neurology. The symptoms of multiple sclerosis vary. These symptoms can include difficulty is speech, fatigue, weakness and pain. The form of multiple sclerosis that is most common is called, relapsing-remitting. Relapsing-remitting multiple sclerosis is characterized as periods of mild to no symptoms with periods of relapses or flare-ups.
The treatment that was given to these individuals aimed to suppress the disease, while preventing ongoing disability. The treatment removed cells that caused the disease and reset the immune system. The treatment consisted of doctors collecting stem cells from the participant and giving them a high dosage of chemotherapy, which is used to deplete the immune system. Then they insert the participant’s stem cells, which is used to rebuild their immune system.
Dr. Shiva Gopal Vasishta is a New Jersey neurologist that is affiliated with Kennedy University Hospital. Dr. Shiva Gopal Vasishta has 40 years of experience in neurology. In 1979, the neurologist completed his studies at Government Medical College. Dr. Shiva Gopal Vasishta was resident at Boston City Hospital.
In addition to specializing in neurology, Dr. Shiva Gopal Vasishta also specializes in psychiatry. His practice is located in Voorhies, NJ. The neurologist is certified by the American Board of Psychiatry and Neurology and holds his NJ State Medical License. Lastly, he is a practicing member of the Eastern Neurodiagnostic Association.